ReviewClinical and translational science2016

Toward Optimum Benefit-Risk and Reduced Access Lag For Cancer Drugs in Asia: A Global Development Framework Guided by Clinical Pharmacology Principles.

K Venkatakrishnan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.